Earlier blood-test detection could help identify pancreatic cancer patients who need more aggressive treatment, an expert ...

Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.

Pancreatic cancer is among the most aggressive types of cancer. Since symptoms appear very late, successful cancer therapy is ...

Treatment for many gastrointestinal cancers is becoming increasingly personalized, thanks to advances in genetic research, targeted therapies and a deeper understanding of how individual tumors behave ...

The CodeBreaK 100 study from Amgen Inc. is a Phase 1/2 trial testing sotorasib in advanced solid tumors with a KRAS p.G12C mutation. It aims to find a safe dose, check how the drug behaves in the body ...

A highly sensitive new blood test can detect tiny traces of one of the deadliest forms of cancer – even when scans suggest ...

Scientists say it has the potential to extend lives by helping doctors identify patients whose disease is more likely to ...

Northwestern Medicine scientists have demonstrated that a highly sensitive blood test can detect traces of pancreatic cancer ...

A groundbreaking blood test can identify even tiny traces of one of the most lethal forms of cancer. The highly sensitive ...

Northwestern Medicine scientists have demonstrated that a highly sensitive blood test can detect traces of pancreatic cancer ...

Researchers tested experimental PCAI compounds against pancreatic cancer cells and found they had powerful anticancer effects. One leading compound blocked more than 90% of cancer cell migration, ...